OptiBiotix Health has entered into a five year agreement with Akums Drugs and Pharmaceuticals to exclusively manufacture and supply products featuring OptiBiotix's cholesterol and blood pressure reducing strain LPLDL in India.

More From BioPortfolio on "OptiBiotix Health signs manufacturing and supply deal in India with Akums"

Relevant Topic

Collaborations in biotechnologyCommercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development.
Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc.
...